Source: FinSMEs

GridX: OncoPrecision Raises $3.3M in Seed Funding

OncoPrecision, a New York, NY and Córdoba, Argentina-based Patient Micro Avatar technology company, raised $3.3m in Seed funding. The round, closed in April, was led by SOSV's IndieBio, GRIDX, New York Ventures (the venture capital arm of the State of New York), Creative Ventures, Fundación Para el Progreso de la Medicina (a diagnostics lab where [...]The post OncoPrecision Raises $3.3M in Seed Funding appeared first on FinSMEs.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Chris Black's photo - CEO of GridX

CEO

Chris Black

CEO Approval Rating

89/100

Read more